Table 3 Multivariate Analysis of Characteristics Associated With 3- and 6-Month Mortality

ECOG-PS

0.006

0.006

 0–1

1

1

 2

1.24 (0.60–2.54)

1.42 (0.73–2.79)

 3–4

3.67 (1.62–8.34)

3.74 (1.67–8.37)

Metastatic disease

2.74 (1.38–5.44)

0.004

2.56 (1.34–4.90)

0.004

 Chemotherapy

0.38 (0.19–0.75)

0.006

0.61 (0.32–1.16)

0.13

 Cancer progression

2.08 (1.02–4.23)

0.04

2.31 (1.14–4.68)

0.02

SAPS II

0.08

0.01

 [0–35]

1

1

 [35–45]

2.74 (1.06–7.08)

2.65 (1.09–6.47)

 [45–58]

3.15 (1.26–7.89)

4.19 (1.76–9.97)

 [58–160]

2.68 (1.04–6.89)

2.55 (1.05–6.20)

TLD before ICU discharge

4.21 (1.80–9.86)

< 0.001

4.00 (1.64–9.77)

0.002